US4489056A
(en)
*
|
1982-06-30 |
1984-12-18 |
Merck & Co., Inc. |
Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances dispersed throughout their matrix or where the polymer matrix surrounds the beneficial substance
|
US4513143A
(en)
*
|
1982-12-01 |
1985-04-23 |
Sri International |
Preparation of ketene acetals
|
US4532335A
(en)
*
|
1983-03-07 |
1985-07-30 |
Sri International |
Preparation of ketene acetals by rearrangement of allyl and substituted allyl acetals
|
US4639366A
(en)
*
|
1984-06-06 |
1987-01-27 |
Merck & Co., Inc. |
Polymers containing pendant acid functionalities and labile backbone bonds
|
US4549010A
(en)
*
|
1984-06-27 |
1985-10-22 |
Merck & Co., Inc. |
Bioerodible poly(ortho ester) thermoplastic elastomer from diketene diacetal
|
US4754745A
(en)
*
|
1984-11-21 |
1988-07-05 |
Horowitz Bruce S |
Conformable sheet material for use in brachytherapy
|
US4697575A
(en)
*
|
1984-11-21 |
1987-10-06 |
Henry Ford Hospital |
Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
|
US4780319A
(en)
*
|
1985-07-08 |
1988-10-25 |
Merck & Co., Inc. |
Organic acids as catalysts for the erosion of polymers
|
US4855132A
(en)
*
|
1986-02-25 |
1989-08-08 |
S R I International |
Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
|
US4764364A
(en)
*
|
1986-02-25 |
1988-08-16 |
S R I International |
Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
|
US4763642A
(en)
*
|
1986-04-07 |
1988-08-16 |
Horowitz Bruce S |
Intracavitational brachytherapy
|
DE3788301D1
(de)
*
|
1986-05-15 |
1994-01-13 |
Hoechst Ag |
Biologisch abbaubare Polymere für Depotzubereitungen mit kontrollierter Wirkstoffabgabe.
|
US4713441A
(en)
*
|
1986-08-01 |
1987-12-15 |
Sandoz Pharmaceuticals Corp. |
Polyacetal hydrogels formed from divinyl ethers and polyols
|
US4842868A
(en)
*
|
1986-09-26 |
1989-06-27 |
Helwing Robert F |
Covalently bonded active agents with carbonium ion base groups
|
DE3700128A1
(de)
*
|
1987-01-03 |
1988-07-14 |
Hoechst Ag |
Biologisch abbaubare poly- (hydroxyalkyl)- aminodicarbonsaeure-derivate, verfahren zu ihrer herstellung und verwendung derselben fuer depotzubereitungen mit kontrollierter wirkstoffabgabe
|
US4913903A
(en)
*
|
1987-02-04 |
1990-04-03 |
Alza Corporation |
Post-surgical applications for bioerodible polymers
|
US4906714A
(en)
*
|
1988-08-02 |
1990-03-06 |
E. I. Du Pont De Nemours And Company |
Partially fluorinated polyesters from ketene acetals and fluorinated vinyl monomers
|
US4957986A
(en)
*
|
1988-08-02 |
1990-09-18 |
E. I. Du Pont De Nemours And Company |
Partially fluorinated polyesters from ketene acetals and fluorine monomers
|
US4957998A
(en)
*
|
1988-08-22 |
1990-09-18 |
Pharmaceutical Delivery Systems, Inc. |
Polymers containing acetal, carboxy-acetal, ortho ester and carboxyortho ester linkages
|
US5108755A
(en)
*
|
1989-04-27 |
1992-04-28 |
Sri International |
Biodegradable composites for internal medical use
|
US4946931A
(en)
*
|
1989-06-14 |
1990-08-07 |
Pharmaceutical Delivery Systems, Inc. |
Polymers containing carboxy-ortho ester and ortho ester linkages
|
US5013821A
(en)
*
|
1989-06-15 |
1991-05-07 |
Pharmaceutical Delivery Systems, Inc. |
Ortho and thio-ortho ester polymer
|
US5030457A
(en)
*
|
1989-08-28 |
1991-07-09 |
Pharmaceutical Delivery Systems, Inc. |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
JPH05502465A
(ja)
*
|
1989-08-28 |
1993-04-28 |
ファーマスーティカル デリバリー システムズ |
治療薬剤の制御放出のために有用な生体内で分解し得るポリマー
|
US5047464A
(en)
*
|
1989-09-20 |
1991-09-10 |
Merck & Co., Inc. |
Bioerodible thermoset elastomers
|
US5217712A
(en)
*
|
1989-09-20 |
1993-06-08 |
Merck & Co., Inc. |
Bioerodible thermoset elastomers
|
DE4002736A1
(de)
*
|
1990-01-31 |
1991-08-01 |
Hoechst Ag |
Biologisch abbaubare polymere, verfahren zu ihrer herstellung und verwendung derselben fuer depotzubereitungen mit kontrollierter wirkstoffabgabe
|
NZ239370A
(en)
*
|
1990-08-22 |
1994-04-27 |
Merck & Co Inc |
Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
|
JPH04120376U
(ja)
*
|
1991-04-16 |
1992-10-28 |
横河電機株式会社 |
リレ−検査回路
|
US5211951A
(en)
*
|
1991-07-24 |
1993-05-18 |
Merck & Co., Inc. |
Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
|
US5254345A
(en)
*
|
1991-10-11 |
1993-10-19 |
Merck & Co., Inc. |
Poly(orthocarbonate acetal) bioerodible polymers
|
US5461140A
(en)
*
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
ES2118408T3
(es)
*
|
1993-05-03 |
1998-09-16 |
Loctite Corp |
Cristales liquidos dispersados en polimeros de tiol y alquenos ricos en electrones.
|
US5401885A
(en)
*
|
1993-06-01 |
1995-03-28 |
Huls America, Inc. |
Method of preparing ortho esters and 1.1-dialkoxycycloalkanes
|
US5442033A
(en)
*
|
1993-07-20 |
1995-08-15 |
Ethicon, Inc. |
Liquid copolymers of epsilon-caprolactone and lactide
|
ES2109136B1
(es)
*
|
1994-04-22 |
1998-07-01 |
Vita Invest Sa |
Polimeros biodegradables de esqueleto carbonado de acetales de centeno y alcoholes, procedimiento para su obtencion y composicion y utilizacion correspondientes.
|
US5811510A
(en)
*
|
1995-04-14 |
1998-09-22 |
General Hospital Corporation |
Biodegradable polyacetal polymers and methods for their formation and use
|
FI98136C
(fi)
*
|
1995-09-27 |
1997-04-25 |
Biocon Oy |
Kudosolosuhteissa hajoava materiaali ja menetelmä sen valmistamiseksi
|
US5968543A
(en)
*
|
1996-01-05 |
1999-10-19 |
Advanced Polymer Systems, Inc. |
Polymers with controlled physical state and bioerodibility
|
US5939453A
(en)
*
|
1998-06-04 |
1999-08-17 |
Advanced Polymer Systems, Inc. |
PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
|
JP2002520287A
(ja)
*
|
1998-07-10 |
2002-07-09 |
ザ・ユニバーシティ・オブ・シドニー |
黄斑変性における血管新生の予防的治療
|
AUPQ496500A0
(en)
*
|
2000-01-06 |
2000-02-03 |
University Of Sydney, The |
Kit
|
US6613355B2
(en)
*
|
2000-05-11 |
2003-09-02 |
A.P. Pharma, Inc. |
Semi-solid delivery vehicle and pharmaceutical compositions
|
US20050042194A1
(en)
|
2000-05-11 |
2005-02-24 |
A.P. Pharma, Inc. |
Semi-solid delivery vehicle and pharmaceutical compositions
|
ATE377048T1
(de)
|
2000-09-06 |
2007-11-15 |
Ap Pharma Inc |
Abbaubare polyacetal-polymere
|
US6590059B2
(en)
*
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
WO2002092661A1
(en)
*
|
2001-05-11 |
2002-11-21 |
Ap Pharma, Inc. |
Peg-poe, peg-poe-peg, and poe-peg-poe block copolymers
|
US6524606B1
(en)
|
2001-11-16 |
2003-02-25 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters containing amine groups
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
US20040062778A1
(en)
*
|
2002-09-26 |
2004-04-01 |
Adi Shefer |
Surface dissolution and/or bulk erosion controlled release compositions and devices
|
US7354574B2
(en)
*
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
US6863782B2
(en)
*
|
2002-11-15 |
2005-03-08 |
A.P. Pharma, Inc. |
Method of preparing di(ketene acetals)
|
US7045589B2
(en)
*
|
2002-11-15 |
2006-05-16 |
A.P. Pharma, Inc. |
Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
|
CA2520775A1
(en)
*
|
2003-03-31 |
2004-10-21 |
Alza Corporation |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
US7056591B1
(en)
|
2003-07-30 |
2006-06-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same
|
US7083802B2
(en)
*
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US7083803B2
(en)
*
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
US20050181018A1
(en)
*
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
US7329413B1
(en)
*
|
2003-11-06 |
2008-02-12 |
Advanced Cardiovascular Systems, Inc. |
Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof
|
US9114198B2
(en)
|
2003-11-19 |
2015-08-25 |
Advanced Cardiovascular Systems, Inc. |
Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
|
US7220816B2
(en)
|
2003-12-16 |
2007-05-22 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same
|
US7435788B2
(en)
|
2003-12-19 |
2008-10-14 |
Advanced Cardiovascular Systems, Inc. |
Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
|
JP2007520496A
(ja)
*
|
2004-02-04 |
2007-07-26 |
レットメッド ピーティーワイ リミテッド |
徐放性ステロイド組成物
|
CA2557216A1
(en)
*
|
2004-02-26 |
2005-09-09 |
Advanced Ocular Systems Limited |
Heparin for the treatment of ocular pathologies
|
US20050192257A1
(en)
*
|
2004-02-26 |
2005-09-01 |
Peyman Gholam A. |
Predictors for patients at risk for glaucoma from steroid therapy
|
US8685431B2
(en)
|
2004-03-16 |
2014-04-01 |
Advanced Cardiovascular Systems, Inc. |
Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
|
US8778014B1
(en)
|
2004-03-31 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings for preventing balloon damage to polymer coated stents
|
SI1755616T1
(sl)
|
2004-04-08 |
2014-04-30 |
Eye Co Pty Ltd. |
Zdravljenje eksudativne retinopatije z mineralkortikoidi
|
US20050261243A1
(en)
*
|
2004-04-21 |
2005-11-24 |
Peyman Gholam A |
Antiprostaglandins for the treatment of ocular pathologies
|
US7820732B2
(en)
|
2004-04-30 |
2010-10-26 |
Advanced Cardiovascular Systems, Inc. |
Methods for modulating thermal and mechanical properties of coatings on implantable devices
|
US20050288481A1
(en)
*
|
2004-04-30 |
2005-12-29 |
Desnoyer Jessica R |
Design of poly(ester amides) for the control of agent-release from polymeric compositions
|
US20050271700A1
(en)
*
|
2004-06-03 |
2005-12-08 |
Desnoyer Jessica R |
Poly(ester amide) coating composition for implantable devices
|
US20050287184A1
(en)
|
2004-06-29 |
2005-12-29 |
Hossainy Syed F A |
Drug-delivery stent formulations for restenosis and vulnerable plaque
|
US7350479B2
(en)
*
|
2004-09-10 |
2008-04-01 |
United States Of America As Represented By The Secretary Of The Army |
System and method for controlling growth of aquatic plants utilizing bio-eroding means implanted in triploid grass carp
|
US7166680B2
(en)
|
2004-10-06 |
2007-01-23 |
Advanced Cardiovascular Systems, Inc. |
Blends of poly(ester amide) polymers
|
US7390497B2
(en)
|
2004-10-29 |
2008-06-24 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) filler blends for modulation of coating properties
|
US8609123B2
(en)
|
2004-11-29 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Derivatized poly(ester amide) as a biobeneficial coating
|
US20060122152A1
(en)
*
|
2004-12-03 |
2006-06-08 |
Peyman Gholam A |
Heparin for the treatment of ocular pathologies
|
US7419504B2
(en)
|
2004-12-27 |
2008-09-02 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide) block copolymers
|
US8007775B2
(en)
|
2004-12-30 |
2011-08-30 |
Advanced Cardiovascular Systems, Inc. |
Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
|
US7202325B2
(en)
*
|
2005-01-14 |
2007-04-10 |
Advanced Cardiovascular Systems, Inc. |
Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles
|
EP1865989A2
(de)
*
|
2005-03-31 |
2007-12-19 |
AP Pharma, Inc. |
Peg-poly(orthoester)-pfropfcopolymere und pharmazeutische zusammensetzungen
|
AU2006230201A1
(en)
*
|
2005-03-31 |
2006-10-05 |
A.P. Pharma, Inc. |
PEG-polyacetal diblock and triblock copolymers and pharmaceutical compositions
|
US20070014760A1
(en)
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
AU2006270041B2
(en)
|
2005-07-18 |
2011-08-18 |
Minu, Llc |
Enhanced ocular neuroprotection/neurostimulation
|
US20070020312A1
(en)
*
|
2005-07-20 |
2007-01-25 |
Desnoyer Jessica R |
Method of fabricating a bioactive agent-releasing implantable medical device
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
US8377462B2
(en)
*
|
2005-07-29 |
2013-02-19 |
Advanced Cardiovascular Systems, Inc. |
PEA-TEMPO/PEA-BZ coatings for controlled delivery of drug from implantable medical devices
|
US7713916B2
(en)
|
2005-09-22 |
2010-05-11 |
Halliburton Energy Services, Inc. |
Orthoester-based surfactants and associated methods
|
US20070066493A1
(en)
*
|
2005-09-22 |
2007-03-22 |
Halliburton Energy Services, Inc. |
Orthoester-based surfactants and associated methods
|
WO2007043672A1
(en)
|
2005-10-11 |
2007-04-19 |
Fujifilm Corporation |
Novel fluorine-containing spiroacetal compound and method of producing the same
|
ES2437581T3
(es)
|
2005-11-17 |
2014-01-13 |
Zogenix, Inc. |
Suministro de formulaciones viscosas por inyección sin aguja
|
US7910152B2
(en)
*
|
2006-02-28 |
2011-03-22 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
|
EP2374472B9
(de)
|
2006-03-16 |
2019-06-12 |
Dyax Corp. |
Zusammensetzungen und Verfahren zur Behandlung von Augenerkrankungen
|
US20070264338A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Shah Devang T |
Base-stabilized polyorthoester formulations
|
US20070264339A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Ap Pharma, Inc. |
Base-stabilized polyorthoester formulations
|
US20070265329A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Devang Shah T |
Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
|
US7306040B1
(en)
*
|
2006-06-02 |
2007-12-11 |
Halliburton Energy Services, Inc. |
Stimuli-degradable gels
|
US20070281870A1
(en)
*
|
2006-06-02 |
2007-12-06 |
Halliburton Energy Services, Inc. |
Stimuli-degradable gels
|
US20090258028A1
(en)
*
|
2006-06-05 |
2009-10-15 |
Abbott Cardiovascular Systems Inc. |
Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
|
US8323676B2
(en)
*
|
2008-06-30 |
2012-12-04 |
Abbott Cardiovascular Systems Inc. |
Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
|
US7458953B2
(en)
*
|
2006-06-20 |
2008-12-02 |
Gholam A. Peyman |
Ocular drainage device
|
EP2044142A2
(de)
*
|
2006-06-29 |
2009-04-08 |
Medtronic, Inc. |
Poly(orthoester)polymere sowie herstellungs- und verwendungsverfahren dafür
|
US7771739B2
(en)
*
|
2006-06-30 |
2010-08-10 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices comprising semi-crystalline poly(ester-amide)
|
US9028859B2
(en)
|
2006-07-07 |
2015-05-12 |
Advanced Cardiovascular Systems, Inc. |
Phase-separated block copolymer coatings for implantable medical devices
|
RU2438708C2
(ru)
*
|
2006-07-10 |
2012-01-10 |
Эсбатек, Эн Элкон Биомедикал Рисёрч Юнит Ллк |
ScFv-АНТИТЕЛА, КОТОРЫЕ ПРОХОДЯТ ЧЕРЕЗ ЭПИТЕЛИАЛЬНЫЙ И/ИЛИ ЭНДОТЕЛИАЛЬНЫЙ СЛОИ
|
US20090181063A1
(en)
*
|
2006-07-13 |
2009-07-16 |
Michael Huy Ngo |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
US7731987B2
(en)
*
|
2006-07-13 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Implantable medical device comprising a pro-healing poly(ester-amide)
|
US8030436B2
(en)
*
|
2006-07-13 |
2011-10-04 |
Advanced Cardiovascular Systems, Inc. |
Poly(ester-amide) elastomers and their use with implantable medical devices
|
US20080014245A1
(en)
*
|
2006-07-14 |
2008-01-17 |
Stephen Pacetti |
Drug-eluting implantable medical device with free radical scavenger for protecting drugs during sterilization and related method
|
US8268347B1
(en)
|
2006-10-24 |
2012-09-18 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
US20080114076A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Alcon Manufacturing Ltd. |
Punctal plug comprising a water-insoluble polymeric matrix
|
EP2409687B1
(de)
|
2006-11-09 |
2014-06-11 |
Alcon Research, Ltd. |
Wasserunlösliche Polymermatrix zur Verabreichung von Medikamenten
|
US20080175882A1
(en)
*
|
2007-01-23 |
2008-07-24 |
Trollsas Mikael O |
Polymers of aliphatic thioester
|
US20080306584A1
(en)
*
|
2007-06-05 |
2008-12-11 |
Pamela Kramer-Brown |
Implantable medical devices for local and regional treatment
|
US8252361B2
(en)
*
|
2007-06-05 |
2012-08-28 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices for local and regional treatment
|
US9737638B2
(en)
*
|
2007-06-20 |
2017-08-22 |
Abbott Cardiovascular Systems, Inc. |
Polyester amide copolymers having free carboxylic acid pendant groups
|
US7927621B2
(en)
*
|
2007-06-25 |
2011-04-19 |
Abbott Cardiovascular Systems Inc. |
Thioester-ester-amide copolymers
|
US8475823B2
(en)
|
2008-04-18 |
2013-07-02 |
Medtronic, Inc. |
Baclofen formulation in a polyorthoester carrier
|
US8956642B2
(en)
|
2008-04-18 |
2015-02-17 |
Medtronic, Inc. |
Bupivacaine formulation in a polyorthoester carrier
|
EP2756756B1
(de)
|
2008-04-28 |
2016-01-06 |
Zogenix, Inc. |
Neuartige Formulierungen zur Behandlung von Migräne
|
US8889172B1
(en)
|
2008-04-30 |
2014-11-18 |
Abbott Cardiovascular Systems Inc. |
Amorphous or semi-crystalline poly(ester amide) polymer with a high glass transition temperature
|
US20110201869A1
(en)
*
|
2008-05-07 |
2011-08-18 |
Obj Limited |
Method and apparatus for enhanced transdermal diffusion
|
US8765162B2
(en)
*
|
2008-06-30 |
2014-07-01 |
Abbott Cardiovascular Systems Inc. |
Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
|
US20100120811A1
(en)
|
2008-07-17 |
2010-05-13 |
Peter Hanson |
Long-acting injectable analgesic formulations for animals
|
US20100047319A1
(en)
*
|
2008-08-21 |
2010-02-25 |
Michael Huy Ngo |
Biodegradable Poly(Ester-Amide) And Poly(Amide) Coatings For Implantable Medical Devices With Enhanced Bioabsorption Times
|
JP2012512163A
(ja)
*
|
2008-12-11 |
2012-05-31 |
エーピー ファーマ, インコーポレイテッド |
ポリオルトエステルおよびそれらの製剤の安定性を高めるための方法
|
EP2488640B1
(de)
|
2009-10-14 |
2018-09-26 |
Nanyang Technological University |
Antiproliferationsmittel
|
EP2343046A1
(de)
|
2010-01-08 |
2011-07-13 |
Nirvana's Tree House B.V. |
Funktionalisierte Triblockcopolymere und Zusammensetzungen, die solche Polymere enthalten
|
EP2575950A4
(de)
|
2010-05-25 |
2014-07-09 |
Internat Scient Pty Ltd |
Verabreichung von mundpflegeprodukten
|
EP2582424A4
(de)
|
2010-06-17 |
2014-08-06 |
Internat Scient Pty Ltd |
Abgabe von hautpflegeprodukten
|
US9949811B2
(en)
|
2011-02-23 |
2018-04-24 |
Boston Scientific Scimed, Inc. |
Pelvic implant and therapeutic agent system and method
|
AU2012220564A1
(en)
|
2011-02-23 |
2013-08-29 |
Ams Research Corporation |
Drug releasing pelvic treatment system and method
|
AU2012340107B2
(en)
|
2011-11-18 |
2017-06-15 |
Regeneron Pharmaceuticals, Inc. |
Polymer protein microparticles
|
US9849180B2
(en)
|
2014-09-15 |
2017-12-26 |
Hui Rong Shen |
Long-acting semi-solid lipid formulations
|
US10220093B2
(en)
|
2013-02-28 |
2019-03-05 |
Mira Pharma Corporation |
Long-acting semi-solid lipid formulations
|
US9744163B2
(en)
|
2013-03-15 |
2017-08-29 |
Heron Therapeutics, Inc. |
Compositions of a polyorthoester and an aprotic solvent
|
US9801945B2
(en)
|
2014-04-21 |
2017-10-31 |
Heron Therapeutics, Inc. |
Long-acting polymeric delivery systems
|
EP3936115A1
(de)
|
2014-04-21 |
2022-01-12 |
Heron Therapeutics, Inc. |
Systeme zur langzeitwirkenden polymerabgabe
|
SI3134070T1
(sl)
|
2014-04-21 |
2021-03-31 |
Heron Therapeutics, Inc. |
Sestave poliortoestra in pomožne snovi iz organske kisline
|
WO2018048460A1
(en)
|
2014-04-21 |
2018-03-15 |
Heron Therapeutics, Inc. |
A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
|
CN106456663A
(zh)
|
2014-06-11 |
2017-02-22 |
国际科学私人有限公司 |
治疗或预防关节退化的装置和方法
|
AU2016342374B2
(en)
|
2015-10-23 |
2022-08-04 |
Lyndra Therapeutics, Inc. |
Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
|
KR20180090881A
(ko)
|
2015-12-08 |
2018-08-13 |
린드라 인코퍼레이티드 |
위 체류 시스템을 위한 기하 구성형태
|
PL3389636T3
(pl)
|
2015-12-16 |
2022-11-28 |
Regeneron Pharmaceuticals, Inc. |
Kompozycje i metody wytwarzania mikrocząstek białkowych
|
AU2017268840B2
(en)
|
2016-05-27 |
2022-02-10 |
Lyndra Therapeutics, Inc. |
Materials architecture for gastric residence systems
|
AU2017336154B2
(en)
|
2016-09-30 |
2023-11-09 |
Lyndra Therapeutics, Inc. |
Gastric residence systems for sustained delivery of adamantane-class drugs
|
US11014941B2
(en)
|
2017-04-24 |
2021-05-25 |
Cocrystal Pharma, Inc. |
Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
|
WO2018227147A1
(en)
|
2017-06-09 |
2018-12-13 |
Lyndra, Inc. |
Gastric residence systems with release rate-modulating films
|
CA3067558A1
(en)
|
2017-06-16 |
2018-12-20 |
Avery Therapeutics, Inc. |
Three dimensional tissue compositions and methods of use
|
WO2019060458A1
(en)
|
2017-09-20 |
2019-03-28 |
Lyndra, Inc. |
ENCAPSULATION OF GASTRIC SYSTEMS
|
US11426418B2
(en)
|
2017-12-06 |
2022-08-30 |
Mira Pharma Corporation |
Injectable long-acting semi-solid gel formulations
|
US10561606B2
(en)
|
2017-12-06 |
2020-02-18 |
Mira Pharma Corporation |
Injectable long-acting local anesthetic semi-solid gel formulations
|
MX2021000917A
(es)
|
2018-07-27 |
2021-06-23 |
Cocrystal Pharma Inc |
Derivados de pirrolo[2,3-b]piridina como inhibidores de la replicación del virus de la gripe.
|
CN113286793B
(zh)
|
2018-09-10 |
2024-04-05 |
共结晶制药公司 |
吡咯并吡嗪和吡啶并三嗪类流感病毒复制抑制剂
|
MX2021004215A
(es)
|
2018-10-17 |
2021-07-15 |
Cocrystal Pharma Inc |
Combinaciones de inhibidores de la replicación del virus de la gripe.
|
EP3887355A1
(de)
|
2018-11-26 |
2021-10-06 |
Cocrystal Pharma, Inc. |
Inhibitoren der influenzavirenreplikation
|
MX2022006236A
(es)
|
2019-11-25 |
2022-06-22 |
Regeneron Pharma |
Formulaciones de liberacion sostenida con emulsiones no acuosas.
|
BR112022013784A2
(pt)
|
2020-01-13 |
2022-10-11 |
Durect Corp |
Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
|
WO2021188620A1
(en)
|
2020-03-17 |
2021-09-23 |
Cocrystal Pharma Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
KR20230008079A
(ko)
|
2020-04-10 |
2023-01-13 |
코크리스탈 파마, 아이엔씨. |
노로바이러스 및 코로나바이러스 복제 억제제
|
AU2021385363A1
(en)
|
2020-11-25 |
2023-06-08 |
Regeneron Pharmaceuticals, Inc. |
Sustained release formulations using non-aqueous membrane emulsification
|
CA3227602A1
(en)
|
2021-08-03 |
2023-02-09 |
Irina C. Jacobson |
Inhibitors for coronaviruses
|